Compare AUROW & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUROW | MIST |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 95.3M |
| IPO Year | 2021 | 2019 |
| Metric | AUROW | MIST |
|---|---|---|
| Price | $0.01 | $0.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.57 |
| AVG Volume (30 Days) | 215.3K | ★ 934.7K |
| Earning Date | 04-30-2025 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,000,000.00 | N/A |
| Revenue This Year | N/A | $125.44 |
| Revenue Next Year | N/A | $462.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $0.63 |
| 52 Week High | $0.87 | $3.06 |
| Indicator | AUROW | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 32.75 | 45.38 |
| Support Level | N/A | $0.63 |
| Resistance Level | $0.03 | $1.42 |
| Average True Range (ATR) | 0.01 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 51.90 |
Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.